1-160128761-C-G
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PM5PP2PP3_StrongPP5
The ENST00000361216.8(ATP1A2):c.1127C>G(p.Thr376Arg) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. T376M) has been classified as Likely pathogenic.
Frequency
Consequence
ENST00000361216.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP1A2 | NM_000702.4 | c.1127C>G | p.Thr376Arg | missense_variant | 9/23 | ENST00000361216.8 | NP_000693.1 | |
ATP1A2 | XM_047421286.1 | c.236C>G | p.Thr79Arg | missense_variant | 2/16 | XP_047277242.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP1A2 | ENST00000361216.8 | c.1127C>G | p.Thr376Arg | missense_variant | 9/23 | 1 | NM_000702.4 | ENSP00000354490 | P1 | |
ATP1A2 | ENST00000392233.7 | c.1127C>G | p.Thr376Arg | missense_variant | 9/23 | 5 | ENSP00000376066 | |||
ATP1A2 | ENST00000447527.1 | c.260C>G | p.Thr87Arg | missense_variant | 2/16 | 2 | ENSP00000411705 | |||
ATP1A2 | ENST00000472488.5 | n.1230C>G | non_coding_transcript_exon_variant | 9/20 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 34
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:1Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 04, 2013 | p.Thr376Arg (ACG>AGG): c.1127 C>G in exon 9 of the ATP1A2 gene (NM_000702.3). The Thr376Arg missense change has not been published as a mutation, nor has it been reported as a benign polymorphism to our knowledge. It was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. Thr376Arg is a non-conservative amino acid substitution of an uncharged Threonine residue with a positively charged Arginine residue at a highly conserved position in the intracellular loop between the M4 and M5 transmembrane domains. A different amino acid substitution at the same position (Thr376Met) co-segregated with familial hemiplegic migraine in two unrelated families and was reported to impair catalytic activity, confirming the functional importance of this position in the protein (Riant et al., 2005; Tavraz et al., 2008). The variant is found in EPILEPSY panel(s). - |
Uncertain significance, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Jun 02, 2020 | - - |
Familial hemiplegic migraine Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 03, 2020 | For these reasons, this variant has been classified as Pathogenic. This variant disrupts the p.Thr376 amino acid residue in ATP1A2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 16088919, 17952365, 18728015). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has been observed in individual(s) with clinical features of alternating hemiplegia of childhood (Invitae). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 204885). This variant is not present in population databases (ExAC no frequency). This sequence change replaces threonine with arginine at codon 376 of the ATP1A2 protein (p.Thr376Arg). The threonine residue is highly conserved and there is a moderate physicochemical difference between threonine and arginine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at